Remoxipride
Back to searchMolecule Structure
Scientific Name
Remoxipride
Description of the Drug
Remoxipride is an discontinued atypical antipsychotic selective for dopamine D2 receptors.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00409
http://www.drugbank.ca/drugs/DB00409
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL121339 | |
PharmGKB | PA164749051 | |
Human Metabolome Database | HMDB0014553 | |
DrugBank | DB00409 | |
PubChem: Thomson Pharma | 14755372 | |
PubChem | 54477 | |
LINCS | LSM-3202 | |
Nikkaji | J138.394I | |
BindingDB | 50026045 | |
EPA CompTox Dashboard | DTXSID6045668 | |
DrugCentral | 2365 | |
Brenda | 147734 | |
ChemicalBook | CB2493967 | |
rxnorm | REMOXIPRIDE HYDROCHLORIDE | REMOXIPRIDE |
PubChem: Drugs of the Future | 12012970 | |
ChEBI | 92948 | |
ZINC | ZINC000002021799 |